Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;42:956-961
Published online before print October 13, 2003, doi: 10.1161/01.HYP.0000097806.45034.45
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
42/5/956    most recent
01.HYP.0000097806.45034.45v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dubus, I.
Right arrow Articles by Combe, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dubus, I.
Right arrow Articles by Combe, C.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Cell biology/structural biology

(Hypertension. 2003;42:956.)
© 2003 American Heart Association, Inc.


Scientific Contributions

Cytoskeletal Reorganization by Mycophenolic Acid Alters Mesangial Cell Migration and Contractility

Isabelle Dubus; Beatrice L’Azou; Myriam Gordien; Yahsou Delmas; Jean-Pierre Labouyrie; Jacques Bonnet; Christian Combe

From Unité INSERM 441 (I.D., Y.D., J.B., C.C.) and Université Bordeaux2 (I.D., B.L’A., M.G., J.-P.L., C.C.), Bordeaux, France.

Correspondence to Dr Isabelle Dubus, Laboratoire de Biochimie, UFR Pharmacie, Université Bordeaux 2, 146, rue Léo Saignat, 33076 Bordeaux cedex, France. E-mail dubus{at}biophar.u-bordeaux2.fr

Cytoskeleton alterations are a hallmark of mesangial cell activation during glomerulosclerosis. The aim of this study was to investigate whether mycophenolic acid (MPA) affects cytoskeletal organization and motility of human mesangial cells. Using the IP15 cell line, we found that treatment with 1 µmol/L MPA inhibited both receptor-dependent (angiotensin II) and receptor-independent (KCl) contractile responses, as well as serum-induced migration activity, suggesting alterations in the intracellular mechanisms that control mesangial cell motility. Immunofluorescence studies of MPA-treated cells provided evidence for decreased membrane disassembly/reassembly of {alpha}-smooth muscle actin and F-actin fibers, which was correlated with sustained quantitative and qualitative modifications of actin-associated proteins: calponin was overexpressed and became associated with actin fibers, whereas phosphorylation levels of cofilin and myosin light chain increased, suggesting both an activation of the mechanisms responsible for actin polymerization and an inhibition of actin-depolymerizing processes. These observations support a stabilizing effect of MPA on the mesangial actin cytoskeleton, which constitutes an additive action by which MPA, beyond its anti-inflammatory, antiproliferative and antifibrotic properties, might protect against excessive mesangial activation in the context of various glomerulopathies and kidney transplantation.


Key Words: mycophenolic acid • mesangium • kidney • glomerulosclerosis • cytoskeleton




This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
S. J. M. Welham, P. R. Riley, A. Wade, M. Hubank, and A. S. Woolf
Maternal diet programs embryonic kidney gene expression
Physiol Genomics, June 16, 2005; 22(1): 48 - 56.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Hoffmann, D. Podlich, B. Hahnel, W. Kriz, and N. Gretz
Angiotensin II Type 1 Receptor Overexpression in Podocytes Induces Glomerulosclerosis in Transgenic Rats
J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1475 - 1487.
[Abstract] [Full Text] [PDF]